Fund Holdings — Avidity Partners Management LP

Total Portfolio Value:
$484.85M
Total Bought:
$97.52M
Total Sold:
$607.44M
Net Transaction:
-$509.92M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Boston Scientific Corporation(BSX)515,000336,000-179,000$46.00M$33.90M6.99%-$12.10M
Dianthus Therapeutics, Inc.(DNTH)2,873,0001,720,902-1,152,098$62.63M$31.22M6.44%-$31.41M
UnitedHealth Group Incorporated(UNH)60,00050,500-9,500$30.35M$26.45M5.46%-$3.90M
CG Oncology, Inc.(CGON)1,097,800980,942-116,858$31.48M$24.02M4.95%-$7.46M
Humana Inc.(HUM)89,20081,000-8,200$22.63M$21.43M4.42%-$1.20M
Natera, Inc.(NTRA)223,800119,200-104,600$35.43M$16.86M3.48%-$18.57M
Regeneron Pharmaceuticals, Inc.(REGN)8,40025,400+17,000$5.98M$16.11M3.32%+$10.13M
Endeavour Silver Corp.(EXK)603,011353,000-250,011$33.88M$15.28M3.15%-$18.60M
Beam Therapeutics Inc.(BEAM)0709,517+709,517$0$13.86M2.86%+$13.86M
Glaukos Corporation(GKOS)170,000134,000-36,000$25.49M$13.19M2.72%-$12.30M
DexCom, Inc.(DXCM)318,000180,000-138,000$24.73M$12.29M2.54%-$12.44M
Ultragenyx Pharmaceutical Inc.(RARE)352,000322,100-29,900$14.81M$11.66M2.41%-$3.15M
Syndax Pharmaceuticals, Inc.(SNDX)1,500,000925,000-575,000$19.83M$11.36M2.34%-$8.47M
Cencora Inc039,300+39,300$0$10.93M2.25%+$10.93M
Jazz Pharmaceuticals plcSHS USD(JAZZ)234,50080,000-154,500$28.88M$9.93M2.05%-$18.95M
Tenet Healthcare Corporation(THC)137,00072,000-65,000$17.29M$9.68M2.00%-$7.61M
Neurocrine Biosciences, Inc.(NBIX)220,40085,700-134,700$30.08M$9.48M1.95%-$20.61M
Danaher Corporation(DHR)67,00044,500-22,500$15.38M$9.12M1.88%-$6.26M
Axsome Therapeutics, Inc.(AXSM)188,00077,000-111,000$15.91M$8.98M1.85%-$6.93M
Insmed Incorporated(INSM)232,800107,000-125,800$16.07M$8.16M1.68%-$7.91M
Organon & Co.(OGN)0535,000+535,000$0$7.97M1.64%+$7.97M
Thermo Fisher Scientific Inc.(TMO)44,60015,500-29,100$23.20M$7.71M1.59%-$15.49M
Xenon Pharmaceuticals Inc.(XENE)474,000229,000-245,000$18.58M$7.68M1.58%-$10.90M
Spdr Ser TrS P BIOTECH
ST STR SP BIOT
094,000+94,000$0$7.62M1.57%+$7.62M
Centessa Pharmaceuticals PlcADS1,165,800529,000-636,800$19.53M$7.61M1.57%-$11.92M
Revolution Medicines, Inc.(RVMD)446,200213,000-233,200$19.52M$7.53M1.55%-$11.99M
Teva Pharmaceutical Industries LimitedADS(TEVA)0481,000+481,000$0$7.39M1.52%+$7.39M
Avantor, Inc.(AVTR)947,000453,000-494,000$19.95M$7.34M1.51%-$12.61M
IDEAYA Biosciences, Inc.(IDYA)1,126,700445,000-681,700$28.96M$7.29M1.50%-$21.67M
Doximity, Inc.CL A(DOCS)0122,500+122,500$0$7.11M1.47%+$7.11M
Janux Therapeutics, Inc.(JANX)741,900258,000-483,900$39.72M$6.97M1.44%-$32.76M
HealthEquity, Inc.(HQY)078,000+78,000$0$6.89M1.42%+$6.89M
Blueprint Medicines Corp176,60068,500-108,100$15.40M$6.06M1.25%-$9.34M
United Therapeutics Corporation(UTHR)016,800+16,800$0$5.18M1.07%+$5.18M
Phathom Pharmaceuticals, Inc.(PHAT)1,390,100800,000-590,100$11.29M$5.02M1.03%-$6.27M
Immunic, Inc.(IMUX)7,966,4004,454,408-3,511,992$7.97M$4.86M1.00%-$3.11M
Bruker Corporation(BRKR)76,300115,000+38,700$4.47M$4.80M0.99%+$327.4K
Perspective Therapeutics, Inc.(CATX)2,694,6002,197,270-497,330$8.60M$4.68M0.97%-$3.92M
Context Therapeutics Inc.(CNTX)7,477,2007,477,2000$7.85M$4.58M0.94%-$3.28M
Oruka Therapeutics, Inc.(ORKA)352,124352,1240$6.83M$3.61M0.75%-$3.21M
uniQure N.V.SHS(QURE)222,000336,200+114,200$3.92M$3.56M0.74%-$356.8K
Biohaven Ltd.(BHVN)222,900145,000-77,900$8.33M$3.49M0.72%-$4.84M
Arvinas, Inc.(ARVN)1,358,000413,162-944,838$26.03M$2.90M0.60%-$23.13M
Acadia Pharmaceuticals Inc0169,000+169,000$0$2.81M0.58%+$2.81M
Royalty Pharma plcCL A(RPRX)087,000+87,000$0$2.71M0.56%+$2.71M
BridgeBio Pharma, Inc.(BBIO)075,000+75,000$0$2.59M0.53%+$2.59M
Kezar Life Sciences Inc
COM NEW
502,600502,6000$3.38M$2.45M0.51%-$924.8K
Akero Therapeutics Inc82,00057,000-25,000$2.28M$2.31M0.48%+$26.1K
Soleno Therapeutics Inc032,000+32,000$0$2.29M0.47%+$2.29M
Capricor Therapeutics, Inc.(CAPR)0239,000+239,000$0$2.27M0.47%+$2.27M
Lexeo Therapeutics, Inc.(LXEO)0645,000+645,000$0$2.24M0.46%+$2.24M
Vera Therapeutics, Inc.CL A(VERA)100,00091,000-9,000$4.23M$2.19M0.45%-$2.04M
REGENXBIO Inc.(RGNX)532,000260,000-272,000$4.11M$1.86M0.38%-$2.25M
Ionis Pharmaceuticals, Inc.(IONS)060,000+60,000$0$1.81M0.37%+$1.81M
Mirum Pharmaceuticals, Inc.(MIRM)666,20040,000-626,200$27.55M$1.80M0.37%-$25.75M
Newamsterdam Pharma Company
ORDINARY SHARES
354,00068,000-286,000$9.10M$1.39M0.29%-$7.71M
agilon health, inc.(AGL)0305,100+305,100$0$1.32M0.27%+$1.32M
SCYNEXIS, Inc.(SCYX)1,228,9101,228,9100$1.49M$1.17M0.24%-$316.9K
Vaxcyte, Inc.(PCVX)023,000+23,000$0$868.5K0.18%+$868.5K
Karyopharm Therapeutics Inc.(KPTI)0134,566+134,566$0$503.3K0.10%+$503.3K
Enliven Therapeutics Inc011,300+11,300$0$222.4K0.05%+$222.4K
Hyperfine, Inc.CL A(HYPR)1,188,178222,174-966,004$1.05M$159.1K0.03%-$886.5K
Reviva Pharmaceutcls Hldgs I0138,000+138,000$0$131.6K0.03%+$131.6K
AbbVie Inc.(ABBV)80,7000-80,700$14.34M$0—-$14.34M
Acadia Healthcare Company, Inc.(ACHC)658,0000-658,000$26.09M$0—-$26.09M
Ascendis Pharma A/SADR(ASND)62,0000-62,000$8.54M$0—-$8.54M
Bluebird Bio Inc81,5550-81,555$680.2K$0—-$680.2K
Bristol-Myers Squibb Company(BMY)215,0000-215,000$12.16M$0—-$12.16M
Cogent Biosciences, Inc.(COGT)287,1040-287,104$2.24M$0—-$2.24M
Dyne Therapeutics, Inc.(DYN)96,0000-96,000$2.26M$0—-$2.26M
Illumina, Inc.(ILMN)109,7000-109,700$14.66M$0—-$14.66M
Incyte Corporation(INCY)129,6000-129,600$8.95M$0—-$8.95M
Intra-Cellular Therapies Inc97,0000-97,000$8.10M$0—-$8.10M
Intuitive Surgical, Inc.(ISRG)64,8000-64,800$33.82M$0—-$33.82M
Karyopharm Therapeutics Inc.(KPTI)2,018,5000-2,018,500$1.37M$0—-$1.37M
Keros Therapeutics, Inc.(KROS)210,0000-210,000$3.32M$0—-$3.32M
Kymera Therapeutics, Inc.(KYMR)500,0000-500,000$20.11M$0—-$20.11M
ORIC Pharmaceuticals, Inc.(ORIC)1,265,2000-1,265,200$10.21M$0—-$10.21M
Rocket Pharmaceuticals, Inc.(RCKT)1,053,3000-1,053,300$13.24M$0—-$13.24M
Surgery Partners, Inc.(SGRY)514,2000-514,200$10.89M$0—-$10.89M
TransMedics Group, Inc.(TMDX)192,4000-192,400$12.00M$0—-$12.00M
Page 1 of 1
Avidity Partners Management LP — 13F Holdings — Q1 2025 | TickerTrail